mesalamine has been researched along with Acquired Form of Epidermolysis Bullosa in 1 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Robinowitz, BN | 1 |
| Towery, DS | 1 |
| Meyers, SW | 1 |
| Durick, WJ | 1 |
| Taira, JW | 1 |
1 other study available for mesalamine and Acquired Form of Epidermolysis Bullosa
| Article | Year |
|---|---|
Successful treatment of epidermolysis bullosa acquisita with mesalazine.
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Epidermolysis Bullosa Acquisita; Fema | 1997 |